Highly specific determination of IDH status using edited in vivo magnetic resonance spectroscopyFrancesca Branzoli, Małgorzata Marjańska, Anna Luisa Di Stefano et al.|Neuro-Oncology|2017Cited by 89
In Vivo 2-Hydroxyglutarate Monitoring With Edited MR Spectroscopy for the Follow-up of <i>IDH</i> -Mutant Diffuse GliomasAnna Luisa Di Stefano, Marc Sanson, Lucia Nichelli et al.|Neurology|2022Cited by 30
Diffusion‐weighted <scp>MR</scp> spectroscopy: Consensus, recommendations, and resources from acquisition to modelingClémence Ligneul, Julien Valette, Henrik Lundell et al.|Magnetic Resonance in Medicine|2023Cited by 29
Diffusion-weighted MR spectroscopy: consensus, recommendations and resources from acquisition to modellingClémence Ligneul, Julien Valette, Chloé Najac et al.|arXiv (Cornell University)|2023Cited by 8
P07.15 Diagnostic value of 2-hydroxyglutarate detection by 1H MR spectroscopy in patients with glioma and correlations with tumor phenotype and tissue dosageAnna Luisa Di Stefano, Marc Sanson, Francesca Branzoli et al.|Neuro-Oncology|2016Cited by 0